Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) EBT (2020 - 2025)

Historic EBT for Stemtech (STEK) over the last 6 years, with Q3 2025 value amounting to -$812541.0.

  • Stemtech's EBT rose 3063.53% to -$812541.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year increase of 4343.4%. This contributed to the annual value of -$3.8 million for FY2024, which is 3054.65% up from last year.
  • Stemtech's EBT amounted to -$812541.0 in Q3 2025, which was up 3063.53% from -$296280.0 recorded in Q2 2025.
  • Stemtech's 5-year EBT high stood at $17.4 million for Q3 2022, and its period low was -$25.0 million during Q2 2022.
  • For the 5-year period, Stemtech's EBT averaged around -$1.4 million, with its median value being -$812541.0 (2025).
  • The largest annual percentage gain for Stemtech's EBT in the last 5 years was 42682.98% (2022), contrasted with its biggest fall of 312906.9% (2022).
  • Stemtech's EBT (Quarter) stood at -$848155.0 in 2021, then skyrocketed by 47.4% to -$446114.0 in 2022, then tumbled by 317.83% to -$1.9 million in 2023, then surged by 78.72% to -$396580.0 in 2024, then crashed by 104.89% to -$812541.0 in 2025.
  • Its EBT stands at -$812541.0 for Q3 2025, versus -$296280.0 for Q2 2025 and -$1.5 million for Q1 2025.